Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
None of the four drugs tested in the WHO’s Solidarity trial reduced mortality or duration of hospitalization.
MK-8507, a long-acting NNRTI, will be tested in a weekly regimen with islatravir.
The study asks whether certain approved therapies or late-stage investigational drugs show promise against COVID-19.
The HIV protease inhibitor combination did not speed recovery or reduce the risk of death in a large study.
An experimental approach to protect HIV-fighting T cells has been cleared for its first human trial.
More diversity would help doctors determine whether coronavirus treatments and vaccines will work for all population groups.
Dr. Anthony Fauci will be a keynote speaker at USCHA in October. In his session, federal leaders will talk about next steps to ending HIV.
We asked participants and presenters at the #AIDS2020Virtual what was compelling to them about the gathering. Here are their responses.
Watch two AIDS experts discuss the links between COVID-19 and HIV—including hydroxychloroquine.
According to a survey, many people with HIV don’t understand how cure trials work.
International ‘dream team’ to use new technologies and prevention approaches to help those at highest risk.
The historic 1917 Clinic in Birmingham will triple in size.
The Food and Drug Administration has approved a new treatment for people living with HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.